Share Price and Basic Stock Data
Last Updated: February 11, 2026, 9:07 pm
| PEG Ratio | 6.32 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Mphasis Ltd, operating in the IT Consulting and Software industry, reported a market capitalization of ₹49,308 Cr and a stock price of ₹2,588. The company demonstrated a steady revenue growth trajectory, with sales figures standing at ₹13,798 Cr for the fiscal year ending March 2023, increasing from ₹11,961 Cr in March 2022. The trailing twelve months (TTM) revenue reached ₹14,906 Cr, indicating a consistent upward trend. Quarterly sales figures reflect a slight fluctuation yet overall resilience; sales in December 2022 were ₹3,506 Cr, and by December 2025, this is projected to reach ₹4,003 Cr. This reflects a compound annual growth rate (CAGR) of approximately 10.6% over the period. Mphasis’s operating profit margin (OPM) was reported at 19%, consistent over multiple quarters, showcasing effective cost management and operational efficiency. The company’s revenue growth can be attributed to its strong positioning in digital transformation services, which continues to gain traction in a rapidly evolving market.
Profitability and Efficiency Metrics
Mphasis’s profitability metrics indicate robust operational performance, with a reported net profit of ₹1,785 Cr for the fiscal year ending March 2025, reflecting a net profit margin of 11.96%. The company’s return on equity (ROE) stood at 18.2%, while return on capital employed (ROCE) was recorded at 22.7%, both of which are favorable compared to industry norms. The interest coverage ratio (ICR) of 17.53x highlights the company’s strong ability to meet its interest obligations, suggesting a low risk of financial distress. The steady operating profit margin of 19% underscores Mphasis’s effective cost control measures. However, the cash conversion cycle (CCC) increased to 73 days in March 2025, which may indicate potential inefficiencies in working capital management. Overall, Mphasis’s financial metrics reflect a healthy balance between revenue growth and profitability, positioning it well within the competitive landscape of IT services.
Balance Sheet Strength and Financial Ratios
The balance sheet of Mphasis exhibits strength, with total reserves amounting to ₹9,432 Cr against borrowings of ₹1,979 Cr as of March 2025. This results in a low debt-to-equity ratio of 0.11, indicating minimal reliance on debt financing. The company’s total assets stood at ₹14,744 Cr, with fixed assets valued at ₹5,781 Cr, reflecting significant investments in infrastructure and technology. The current ratio of 1.57 and quick ratio of 1.57 suggest a solid liquidity position, enabling Mphasis to cover short-term liabilities effectively. Furthermore, the price-to-book value (P/BV) ratio stood at 4.94x, which is relatively high, indicating market confidence in the company’s growth prospects relative to its book value. The efficiency ratios, including the cash conversion cycle and return on capital employed, provide insight into operational effectiveness, reinforcing Mphasis’s status as a financially sound entity in the IT consulting sector.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Mphasis reflects a diversified ownership structure, with promoters holding 40.10% of the equity, while foreign institutional investors (FIIs) accounted for 18.52%, and domestic institutional investors (DIIs) held 37.08%. This distribution indicates a balanced investment appeal, attracting both local and foreign investors. The gradual decrease in promoter holding from 55.65% in December 2022 to 40.10% in September 2025 raises questions about long-term commitment, though it has been offset by a rising stake from DIIs, which increased from 19.54% to 37.08% in the same period. The total number of shareholders stood at 1,45,611, reflecting a stable investor base. The consistent dividend payout ratio, reported at 61.10%, further signifies the management’s commitment to returning value to shareholders, enhancing investor confidence in the company’s future performance.
Outlook, Risks, and Final Insight
The outlook for Mphasis appears positive, supported by its strong revenue growth and profitability metrics. However, potential risks include the rising cash conversion cycle, which could impact liquidity if not managed effectively. Additionally, the decreasing promoter shareholding may raise concerns among investors regarding long-term governance and control. On the other hand, the increasing trend in institutional investment suggests confidence in Mphasis’s strategic direction and operational capabilities. The company is well-positioned to capitalize on the growing demand for digital transformation services, which could drive future growth. The ability to manage operational efficiencies while navigating potential risks will be crucial for sustaining its competitive edge. Overall, Mphasis’s financial health and market positioning provide a solid foundation for future expansion and shareholder value creation.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| IDream Film Infrastructure Company Ltd | 4.50 Cr. | 300 | 332/114 | 302 | 0.00 % | % | % | 10.0 | |
| I Power Solutions India Ltd | 13.8 Cr. | 23.4 | 23.4/15.9 | 11.0 | 0.00 % | 11.6 % | 16.9 % | 10.0 | |
| Hypersoft Technologies Ltd | 125 Cr. | 76.8 | 101/19.4 | 61.2 | 9.97 | 0.00 % | 20.6 % | 9.07 % | 10.0 |
| Euphoria Infotech (India) Ltd | 10.9 Cr. | 37.4 | 64.9/32.4 | 7.34 | 58.7 | 0.00 % | 16.2 % | 11.5 % | 10.0 |
| AccelerateBS India Ltd | 51.7 Cr. | 150 | 153/67.0 | 35.2 | 15.0 | 0.67 % | 22.2 % | 17.6 % | 10.0 |
| Industry Average | 111,197.75 Cr | 782.63 | 44.54 | 156.22 | 0.81% | 20.61% | 18.63% | 7.00 |
Quarterly Result
| Metric | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3,506 | 3,361 | 3,252 | 3,276 | 3,338 | 3,412 | 3,422 | 3,536 | 3,561 | 3,710 | 3,732 | 3,902 | 4,003 |
| Expenses | 2,889 | 2,763 | 2,665 | 2,681 | 2,737 | 2,773 | 2,804 | 2,888 | 2,883 | 3,007 | 3,030 | 3,180 | 3,252 |
| Operating Profit | 618 | 599 | 587 | 596 | 601 | 639 | 619 | 648 | 678 | 703 | 703 | 722 | 750 |
| OPM % | 18% | 18% | 18% | 18% | 18% | 19% | 18% | 18% | 19% | 19% | 19% | 18% | 19% |
| Other Income | 40 | 43 | 50 | 49 | 54 | 64 | 74 | 59 | 63 | 60 | 81 | 75 | 27 |
| Interest | 24 | 24 | 24 | 34 | 53 | 50 | 50 | 40 | 39 | 36 | 42 | 44 | 41 |
| Depreciation | 82 | 83 | 87 | 89 | 103 | 131 | 105 | 104 | 132 | 135 | 132 | 128 | 143 |
| Profit before tax | 551 | 534 | 526 | 522 | 499 | 522 | 537 | 563 | 569 | 591 | 610 | 625 | 593 |
| Tax % | 25% | 24% | 25% | 25% | 25% | 25% | 25% | 25% | 25% | 24% | 28% | 25% | 25% |
| Net Profit | 412 | 405 | 396 | 392 | 374 | 393 | 405 | 423 | 428 | 446 | 442 | 469 | 442 |
| EPS in Rs | 21.89 | 21.51 | 21.01 | 20.78 | 19.79 | 20.81 | 21.39 | 22.37 | 22.56 | 23.49 | 23.22 | 24.65 | 23.21 |
Last Updated: February 4, 2026, 11:03 pm
Below is a detailed analysis of the quarterly data for Mphasis Ltd based on the most recent figures (Dec 2025) and their trends compared to the previous period:
- For Sales, as of Dec 2025, the value is 4,003.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,902.00 Cr. (Sep 2025) to 4,003.00 Cr., marking an increase of 101.00 Cr..
- For Expenses, as of Dec 2025, the value is 3,252.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,180.00 Cr. (Sep 2025) to 3,252.00 Cr., marking an increase of 72.00 Cr..
- For Operating Profit, as of Dec 2025, the value is 750.00 Cr.. The value appears strong and on an upward trend. It has increased from 722.00 Cr. (Sep 2025) to 750.00 Cr., marking an increase of 28.00 Cr..
- For OPM %, as of Dec 2025, the value is 19.00%. The value appears strong and on an upward trend. It has increased from 18.00% (Sep 2025) to 19.00%, marking an increase of 1.00%.
- For Other Income, as of Dec 2025, the value is 27.00 Cr.. The value appears to be declining and may need further review. It has decreased from 75.00 Cr. (Sep 2025) to 27.00 Cr., marking a decrease of 48.00 Cr..
- For Interest, as of Dec 2025, the value is 41.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 44.00 Cr. (Sep 2025) to 41.00 Cr., marking a decrease of 3.00 Cr..
- For Depreciation, as of Dec 2025, the value is 143.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 128.00 Cr. (Sep 2025) to 143.00 Cr., marking an increase of 15.00 Cr..
- For Profit before tax, as of Dec 2025, the value is 593.00 Cr.. The value appears to be declining and may need further review. It has decreased from 625.00 Cr. (Sep 2025) to 593.00 Cr., marking a decrease of 32.00 Cr..
- For Tax %, as of Dec 2025, the value is 25.00%. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 25.00%.
- For Net Profit, as of Dec 2025, the value is 442.00 Cr.. The value appears to be declining and may need further review. It has decreased from 469.00 Cr. (Sep 2025) to 442.00 Cr., marking a decrease of 27.00 Cr..
- For EPS in Rs, as of Dec 2025, the value is 23.21. The value appears to be declining and may need further review. It has decreased from 24.65 (Sep 2025) to 23.21, marking a decrease of 1.44.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:57 am
| Metric | Mar 2014n n 5m | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,594 | 5,795 | 6,081 | 6,076 | 6,546 | 7,731 | 8,844 | 9,722 | 11,961 | 13,798 | 13,279 | 14,230 | 14,906 |
| Expenses | 2,154 | 4,925 | 5,218 | 5,108 | 5,483 | 6,407 | 7,193 | 7,919 | 9,844 | 11,365 | 10,857 | 11,583 | 12,101 |
| Operating Profit | 440 | 870 | 863 | 969 | 1,062 | 1,324 | 1,650 | 1,803 | 2,118 | 2,434 | 2,422 | 2,647 | 2,805 |
| OPM % | 17% | 15% | 14% | 16% | 16% | 17% | 19% | 19% | 18% | 18% | 18% | 19% | 19% |
| Other Income | 44 | 194 | 172 | 223 | 149 | 177 | 178 | 133 | 160 | 162 | 218 | 255 | 278 |
| Interest | 11 | 28 | 24 | 14 | 13 | 17 | 81 | 63 | 74 | 97 | 161 | 166 | 161 |
| Depreciation | 50 | 98 | 121 | 79 | 71 | 76 | 232 | 242 | 291 | 325 | 410 | 476 | 527 |
| Profit before tax | 422 | 938 | 890 | 1,099 | 1,128 | 1,407 | 1,515 | 1,631 | 1,913 | 2,173 | 2,068 | 2,260 | 2,395 |
| Tax % | 28% | 28% | 29% | 28% | 26% | 24% | 22% | 25% | 25% | 25% | 25% | 25% | |
| Net Profit | 303 | 675 | 632 | 792 | 838 | 1,073 | 1,185 | 1,217 | 1,431 | 1,638 | 1,555 | 1,702 | 1,785 |
| EPS in Rs | 14.40 | 32.10 | 30.05 | 37.62 | 43.34 | 57.64 | 63.52 | 65.06 | 76.19 | 86.94 | 82.27 | 89.55 | 93.92 |
| Dividend Payout % | 49% | 50% | 67% | 45% | 46% | 47% | 55% | 100% | 60% | 58% | 67% | 64% |
YoY Net Profit Growth
| Year | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -6.37% | 25.32% | 5.81% | 28.04% | 10.44% | 2.70% | 17.58% | 14.47% | -5.07% | 9.45% |
| Change in YoY Net Profit Growth (%) | 0.00% | 31.69% | -19.51% | 22.23% | -17.60% | -7.74% | 14.88% | -3.12% | -19.53% | 14.52% |
Mphasis Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2015-2016 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 10% |
| 3 Years: | 6% |
| TTM: | 8% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 7% |
| 3 Years: | 6% |
| TTM: | 11% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 22% |
| 5 Years: | 20% |
| 3 Years: | 12% |
| 1 Year: | -7% |
| Return on Equity | |
|---|---|
| 10 Years: | 18% |
| 5 Years: | 20% |
| 3 Years: | 19% |
| Last Year: | 18% |
Last Updated: September 5, 2025, 11:20 am
Balance Sheet
Last Updated: December 4, 2025, 1:40 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 210 | 210 | 210 | 210 | 193 | 186 | 187 | 187 | 188 | 188 | 189 | 190 | 190 |
| Reserves | 4,905 | 5,270 | 5,645 | 5,942 | 5,289 | 5,064 | 5,643 | 6,340 | 6,755 | 7,746 | 8,606 | 9,438 | 9,432 |
| Borrowings | 540 | 575 | 461 | 260 | 390 | 543 | 571 | 513 | 527 | 198 | 1,544 | 1,116 | 1,979 |
| Other Liabilities | 1,320 | 1,312 | 1,092 | 889 | 1,109 | 1,576 | 2,339 | 2,324 | 3,214 | 3,373 | 3,662 | 4,000 | 4,672 |
| Total Liabilities | 6,974 | 7,367 | 7,408 | 7,301 | 6,980 | 7,368 | 8,740 | 9,365 | 10,684 | 11,506 | 14,000 | 14,744 | 16,273 |
| Fixed Assets | 2,404 | 2,334 | 1,597 | 1,921 | 1,884 | 2,170 | 3,013 | 3,020 | 3,774 | 4,060 | 5,533 | 5,781 | 6,091 |
| CWIP | 6 | 20 | 56 | 1 | 2 | 3 | 17 | 3 | 11 | 32 | 61 | 0 | 1 |
| Investments | 1,815 | 1,443 | 2,122 | 2,396 | 1,782 | 1,329 | 1,326 | 1,846 | 1,813 | 1,753 | 3,090 | 2,208 | 1,464 |
| Other Assets | 2,748 | 3,569 | 3,633 | 2,983 | 3,312 | 3,866 | 4,384 | 4,496 | 5,087 | 5,662 | 5,316 | 6,754 | 8,718 |
| Total Assets | 6,974 | 7,367 | 7,408 | 7,301 | 6,980 | 7,368 | 8,740 | 9,365 | 10,684 | 11,506 | 14,000 | 14,744 | 16,273 |
Below is a detailed analysis of the balance sheet data for Mphasis Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 190.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 190.00 Cr..
- For Reserves, as of Sep 2025, the value is 9,432.00 Cr.. The value appears to be declining and may need further review. It has decreased from 9,438.00 Cr. (Mar 2025) to 9,432.00 Cr., marking a decrease of 6.00 Cr..
- For Borrowings, as of Sep 2025, the value is 1,979.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 1,116.00 Cr. (Mar 2025) to 1,979.00 Cr., marking an increase of 863.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 4,672.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4,000.00 Cr. (Mar 2025) to 4,672.00 Cr., marking an increase of 672.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 16,273.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 14,744.00 Cr. (Mar 2025) to 16,273.00 Cr., marking an increase of 1,529.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 6,091.00 Cr.. The value appears strong and on an upward trend. It has increased from 5,781.00 Cr. (Mar 2025) to 6,091.00 Cr., marking an increase of 310.00 Cr..
- For CWIP, as of Sep 2025, the value is 1.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2025) to 1.00 Cr., marking an increase of 1.00 Cr..
- For Investments, as of Sep 2025, the value is 1,464.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,208.00 Cr. (Mar 2025) to 1,464.00 Cr., marking a decrease of 744.00 Cr..
- For Other Assets, as of Sep 2025, the value is 8,718.00 Cr.. The value appears strong and on an upward trend. It has increased from 6,754.00 Cr. (Mar 2025) to 8,718.00 Cr., marking an increase of 1,964.00 Cr..
- For Total Assets, as of Sep 2025, the value is 16,273.00 Cr.. The value appears strong and on an upward trend. It has increased from 14,744.00 Cr. (Mar 2025) to 16,273.00 Cr., marking an increase of 1,529.00 Cr..
Notably, the Reserves (9,432.00 Cr.) exceed the Borrowings (1,979.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014n n 5m | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 440.00 | 295.00 | 402.00 | 709.00 | -389.00 | -542.00 | -570.00 | -512.00 | -525.00 | -196.00 | 1.00 | 1.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 109 | 39 | 39 | 38 | 45 | 45 | 34 | 35 | 68 | 67 | 67 | 73 |
| Inventory Days | ||||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 109 | 39 | 39 | 38 | 45 | 45 | 34 | 35 | 68 | 67 | 67 | 73 |
| Working Capital Days | 22 | -5 | 20 | 29 | 21 | 19 | 6 | 15 | 13 | 19 | -27 | -22 |
| ROCE % | 16% | 15% | 18% | 19% | 24% | 26% | 25% | 27% | 29% | 24% | 23% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Kotak Midcap Fund | 7,771,095 | 3.58 | 2169.07 | 6,593,880 | 2025-12-15 04:18:40 | 17.85% |
| HDFC Mid Cap Fund | 4,433,657 | 1.34 | 1237.52 | 4,182,210 | 2025-12-15 04:18:40 | 6.01% |
| ICICI Prudential Technology Fund | 2,377,975 | 4.18 | 663.74 | 2,336,725 | 2026-01-26 00:19:31 | 1.77% |
| Kotak Large & Midcap Fund | 2,200,000 | 2.04 | 614.06 | N/A | N/A | N/A |
| Kotak Multicap Fund | 1,652,887 | 2 | 461.35 | 1,702,887 | 2025-12-15 04:18:40 | -2.94% |
| ICICI Prudential Focused Equity Fund | 1,553,625 | 2.98 | 433.65 | N/A | N/A | N/A |
| HDFC Large and Mid Cap Fund | 1,537,999 | 1.48 | 429.29 | N/A | N/A | N/A |
| HDFC Balanced Advantage Fund | 1,257,231 | 0.32 | 350.92 | N/A | N/A | N/A |
| DSP Mid Cap Fund | 1,246,962 | 1.78 | 348.05 | N/A | N/A | N/A |
| Kotak Balanced Advantage Fund | 1,154,521 | 1.81 | 322.25 | 1,155,896 | 2026-01-26 02:44:31 | -0.12% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 89.87 | 82.42 | 87.05 | 76.38 | 65.18 |
| Diluted EPS (Rs.) | 89.36 | 81.83 | 86.37 | 75.61 | 64.43 |
| Cash EPS (Rs.) | 114.61 | 103.98 | 104.20 | 91.66 | 77.98 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 506.53 | 465.31 | 421.15 | 369.66 | 348.93 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 506.53 | 465.31 | 421.15 | 369.66 | 348.93 |
| Revenue From Operations / Share (Rs.) | 748.62 | 702.55 | 732.38 | 636.84 | 519.77 |
| PBDIT / Share (Rs.) | 152.67 | 139.66 | 137.76 | 121.29 | 103.49 |
| PBIT / Share (Rs.) | 127.61 | 117.94 | 120.50 | 105.81 | 90.56 |
| PBT / Share (Rs.) | 118.90 | 109.43 | 115.34 | 101.84 | 87.17 |
| Net Profit / Share (Rs.) | 89.55 | 82.26 | 86.94 | 76.18 | 65.05 |
| NP After MI And SOA / Share (Rs.) | 89.55 | 82.26 | 86.94 | 76.18 | 65.05 |
| PBDIT Margin (%) | 20.39 | 19.87 | 18.81 | 19.04 | 19.91 |
| PBIT Margin (%) | 17.04 | 16.78 | 16.45 | 16.61 | 17.42 |
| PBT Margin (%) | 15.88 | 15.57 | 15.74 | 15.99 | 16.77 |
| Net Profit Margin (%) | 11.96 | 11.70 | 11.87 | 11.96 | 12.51 |
| NP After MI And SOA Margin (%) | 11.96 | 11.70 | 11.87 | 11.96 | 12.51 |
| Return on Networth / Equity (%) | 17.67 | 17.67 | 20.64 | 20.60 | 18.64 |
| Return on Capital Employeed (%) | 23.19 | 22.45 | 25.76 | 25.32 | 23.34 |
| Return On Assets (%) | 11.41 | 11.00 | 14.10 | 13.30 | 12.94 |
| Total Debt / Equity (X) | 0.11 | 0.17 | 0.02 | 0.07 | 0.07 |
| Asset Turnover Ratio (%) | 0.98 | 1.03 | 1.05 | 0.90 | 0.75 |
| Current Ratio (X) | 1.57 | 1.58 | 2.13 | 1.96 | 2.40 |
| Quick Ratio (X) | 1.57 | 1.58 | 2.13 | 1.96 | 2.40 |
| Dividend Payout Ratio (NP) (%) | 61.10 | 60.64 | 52.82 | 85.08 | 53.66 |
| Dividend Payout Ratio (CP) (%) | 47.74 | 47.97 | 44.07 | 70.71 | 44.76 |
| Earning Retention Ratio (%) | 38.90 | 39.36 | 47.18 | 14.92 | 46.34 |
| Cash Earning Retention Ratio (%) | 52.26 | 52.03 | 55.93 | 29.29 | 55.24 |
| Interest Coverage Ratio (X) | 17.53 | 16.41 | 26.69 | 30.62 | 30.53 |
| Interest Coverage Ratio (Post Tax) (X) | 11.28 | 10.67 | 17.84 | 20.23 | 20.19 |
| Enterprise Value (Cr.) | 47038.62 | 45867.38 | 32991.41 | 62998.79 | 32810.46 |
| EV / Net Operating Revenue (X) | 3.31 | 3.45 | 2.39 | 5.27 | 3.37 |
| EV / EBITDA (X) | 16.21 | 17.38 | 12.71 | 27.65 | 16.95 |
| MarketCap / Net Operating Revenue (X) | 3.34 | 3.40 | 2.45 | 5.30 | 3.43 |
| Retention Ratios (%) | 38.89 | 39.35 | 47.17 | 14.91 | 46.33 |
| Price / BV (X) | 4.94 | 5.13 | 4.27 | 9.13 | 5.11 |
| Price / Net Operating Revenue (X) | 3.34 | 3.40 | 2.45 | 5.30 | 3.43 |
| EarningsYield | 0.03 | 0.03 | 0.04 | 0.02 | 0.03 |
After reviewing the key financial ratios for Mphasis Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 89.87. This value is within the healthy range. It has increased from 82.42 (Mar 24) to 89.87, marking an increase of 7.45.
- For Diluted EPS (Rs.), as of Mar 25, the value is 89.36. This value is within the healthy range. It has increased from 81.83 (Mar 24) to 89.36, marking an increase of 7.53.
- For Cash EPS (Rs.), as of Mar 25, the value is 114.61. This value is within the healthy range. It has increased from 103.98 (Mar 24) to 114.61, marking an increase of 10.63.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 506.53. It has increased from 465.31 (Mar 24) to 506.53, marking an increase of 41.22.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 506.53. It has increased from 465.31 (Mar 24) to 506.53, marking an increase of 41.22.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 748.62. It has increased from 702.55 (Mar 24) to 748.62, marking an increase of 46.07.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 152.67. This value is within the healthy range. It has increased from 139.66 (Mar 24) to 152.67, marking an increase of 13.01.
- For PBIT / Share (Rs.), as of Mar 25, the value is 127.61. This value is within the healthy range. It has increased from 117.94 (Mar 24) to 127.61, marking an increase of 9.67.
- For PBT / Share (Rs.), as of Mar 25, the value is 118.90. This value is within the healthy range. It has increased from 109.43 (Mar 24) to 118.90, marking an increase of 9.47.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 89.55. This value is within the healthy range. It has increased from 82.26 (Mar 24) to 89.55, marking an increase of 7.29.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 89.55. This value is within the healthy range. It has increased from 82.26 (Mar 24) to 89.55, marking an increase of 7.29.
- For PBDIT Margin (%), as of Mar 25, the value is 20.39. This value is within the healthy range. It has increased from 19.87 (Mar 24) to 20.39, marking an increase of 0.52.
- For PBIT Margin (%), as of Mar 25, the value is 17.04. This value is within the healthy range. It has increased from 16.78 (Mar 24) to 17.04, marking an increase of 0.26.
- For PBT Margin (%), as of Mar 25, the value is 15.88. This value is within the healthy range. It has increased from 15.57 (Mar 24) to 15.88, marking an increase of 0.31.
- For Net Profit Margin (%), as of Mar 25, the value is 11.96. This value exceeds the healthy maximum of 10. It has increased from 11.70 (Mar 24) to 11.96, marking an increase of 0.26.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 11.96. This value is within the healthy range. It has increased from 11.70 (Mar 24) to 11.96, marking an increase of 0.26.
- For Return on Networth / Equity (%), as of Mar 25, the value is 17.67. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 17.67.
- For Return on Capital Employeed (%), as of Mar 25, the value is 23.19. This value is within the healthy range. It has increased from 22.45 (Mar 24) to 23.19, marking an increase of 0.74.
- For Return On Assets (%), as of Mar 25, the value is 11.41. This value is within the healthy range. It has increased from 11.00 (Mar 24) to 11.41, marking an increase of 0.41.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.11. This value is within the healthy range. It has decreased from 0.17 (Mar 24) to 0.11, marking a decrease of 0.06.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.98. It has decreased from 1.03 (Mar 24) to 0.98, marking a decrease of 0.05.
- For Current Ratio (X), as of Mar 25, the value is 1.57. This value is within the healthy range. It has decreased from 1.58 (Mar 24) to 1.57, marking a decrease of 0.01.
- For Quick Ratio (X), as of Mar 25, the value is 1.57. This value is within the healthy range. It has decreased from 1.58 (Mar 24) to 1.57, marking a decrease of 0.01.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 61.10. This value exceeds the healthy maximum of 50. It has increased from 60.64 (Mar 24) to 61.10, marking an increase of 0.46.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 47.74. This value is within the healthy range. It has decreased from 47.97 (Mar 24) to 47.74, marking a decrease of 0.23.
- For Earning Retention Ratio (%), as of Mar 25, the value is 38.90. This value is below the healthy minimum of 40. It has decreased from 39.36 (Mar 24) to 38.90, marking a decrease of 0.46.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 52.26. This value is within the healthy range. It has increased from 52.03 (Mar 24) to 52.26, marking an increase of 0.23.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 17.53. This value is within the healthy range. It has increased from 16.41 (Mar 24) to 17.53, marking an increase of 1.12.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 11.28. This value is within the healthy range. It has increased from 10.67 (Mar 24) to 11.28, marking an increase of 0.61.
- For Enterprise Value (Cr.), as of Mar 25, the value is 47,038.62. It has increased from 45,867.38 (Mar 24) to 47,038.62, marking an increase of 1,171.24.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.31. This value exceeds the healthy maximum of 3. It has decreased from 3.45 (Mar 24) to 3.31, marking a decrease of 0.14.
- For EV / EBITDA (X), as of Mar 25, the value is 16.21. This value exceeds the healthy maximum of 15. It has decreased from 17.38 (Mar 24) to 16.21, marking a decrease of 1.17.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 3.34. This value exceeds the healthy maximum of 3. It has decreased from 3.40 (Mar 24) to 3.34, marking a decrease of 0.06.
- For Retention Ratios (%), as of Mar 25, the value is 38.89. This value is within the healthy range. It has decreased from 39.35 (Mar 24) to 38.89, marking a decrease of 0.46.
- For Price / BV (X), as of Mar 25, the value is 4.94. This value exceeds the healthy maximum of 3. It has decreased from 5.13 (Mar 24) to 4.94, marking a decrease of 0.19.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 3.34. This value exceeds the healthy maximum of 3. It has decreased from 3.40 (Mar 24) to 3.34, marking a decrease of 0.06.
- For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.03.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Mphasis Ltd:
- Net Profit Margin: 11.96%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 23.19% (Industry Average ROCE: 20.61%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 17.67% (Industry Average ROE: 18.63%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 11.28
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.57
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 27 (Industry average Stock P/E: 44.54)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.11
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 11.96%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| IT Consulting & Software | Bagmane World Technology Center, Bengaluru Karnataka 560048 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Ms. Jan Kathleen Hier | Chairman |
| Mr. Nitin Rakesh | Managing Director & CEO |
| Mr. Marshall Jan Lux | Non Executive Director |
| Mr. Amit Dalmia | Non Executive Director |
| Mr. Amit Dixit | Non Executive Director |
| Mr. David Lawrence Johnson | Non Executive Director |
| Ms. Courtney Della Cava | Non Executive Director |
| Mr. Kabir Mathur | Non Executive Director |
| Mr. Pankaj Sood | Non Executive Director |
| Mr. Girish Paranjpe | Independent Director |
| Ms. Maureen Anne Erasmus | Independent Director |
| Mr. Sunil Gulati | Independent Director |
FAQ
What is the intrinsic value of Mphasis Ltd?
Mphasis Ltd's intrinsic value (as of 11 February 2026) is ₹2115.63 which is 18.25% lower the current market price of ₹2,588.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹49,308 Cr. market cap, FY2025-2026 high/low of ₹3,037/2,025, reserves of ₹9,432 Cr, and liabilities of ₹16,273 Cr.
What is the Market Cap of Mphasis Ltd?
The Market Cap of Mphasis Ltd is 49,308 Cr..
What is the current Stock Price of Mphasis Ltd as on 11 February 2026?
The current stock price of Mphasis Ltd as on 11 February 2026 is ₹2,588.
What is the High / Low of Mphasis Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Mphasis Ltd stocks is ₹3,037/2,025.
What is the Stock P/E of Mphasis Ltd?
The Stock P/E of Mphasis Ltd is 27.0.
What is the Book Value of Mphasis Ltd?
The Book Value of Mphasis Ltd is 505.
What is the Dividend Yield of Mphasis Ltd?
The Dividend Yield of Mphasis Ltd is 2.20 %.
What is the ROCE of Mphasis Ltd?
The ROCE of Mphasis Ltd is 22.7 %.
What is the ROE of Mphasis Ltd?
The ROE of Mphasis Ltd is 18.2 %.
What is the Face Value of Mphasis Ltd?
The Face Value of Mphasis Ltd is 10.0.